Lyra Therapeutics: Q2 Earnings Insights

 

Lyra Therapeutics LYRA reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Lyra Therapeutics missed estimated earnings by 16.22%, reporting an EPS of $-0.43 versus an estimate of $-0.37.

Revenue was up $407 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.37 which was followed by a 0.41% increase in the share price the next day.

 

To track all earnings releases for Lyra Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

LYRA Logo
LYRALyra Therapeutics Inc
$11.501.50%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
54.90
Growth
Not Available
Quality
Not Available
Value
47.37
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...